Code Bio Overview
- Founded
- 2020
- Status
- Private
- Employees
- 17
- Latest Deal Type
- Seed
- Latest Deal Amount
- $10M
- Investors
- 6
Code Bio General Information
Description
Developer of a non-viral gene therapy designed to treat serious and life-threatening genetic diseases. The company's therapy is leveraging a novel proprietary multivalent synthetic DNA delivery platform, 3DNA, that can overcome many of the challenges inherent with viral-based gene therapies, such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity, enabling physicians to treat patients with rare and prevalent genetic diseases.
Contact Information
- 2801 Sterling Drive
- Hatfield, PA 19440
- United States
Code Bio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Seed Round | 20-Apr-2021 | $10M | 0000 | 0000 | Completed | Generating Revenue |
Code Bio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Code Bio Executive Team (5)
Code Bio Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Brian McVeigh | Self | Co-Founder, Chief Executive Officer & Chairman | 000 0000 |
Dmitry Kuzmin Ph.D | 4BIO Capital Partners | Board Member | 000 0000 |
Edward Mathers | New Enterprise Associates | Board Member | 000 0000 |
Joseph Truitt | Self | Board Member | 000 0000 |
Robert Lin Ph.D | Self | Board Member | 000 0000 |
Code Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCode Bio Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
4BIO Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
CureDuchenne Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
New Enterprise Associates | Venture Capital | Minority | 000 0000 | 000000 0 | |
T1D Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
Takeda Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |